FDA Issues Final Guidance on Human Factors Documentation for Medical Device Submissions

The U.S. Food and Drug Administration (FDA) has released final guidance detailing the expected content for human factors information in medical device regulatory submissions. This document outlines the agency’s requirements for manufacturers to demonstrate that users can operate devices safely and effectively, specifically focusing on the mitigation of use-related risks during the design and development process.

The guidance clarifies the documentation manufacturers must provide to support their human factors engineering (HFE) and usability engineering processes. It specifies that companies must submit a comprehensive report detailing the identification of potential use errors, the implementation of risk control measures, and the results of summative usability testing. The FDA expects these submissions to show that the device’s user interface minimizes the likelihood of errors that could result in harm. Furthermore, the document provides instructions on how firms should integrate these findings into their premarket notification or premarket approval applications, ensuring that the data aligns with established international standards for medical device usability.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

Author

GOAI